Skip to content

Th Effects of a Drug Dexmedotemidine in Regional Anesthesia in Participants Undergoing Upper Limb Surgeries

Dexmedetomidine as an Adjuvant to Local Anesthesia in Supraclavicular Plexus Block, A Randomized Control Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981951
Enrollment
70
Registered
2021-07-29
Start date
2020-10-01
Completion date
2024-08-31
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraclavicular Brachial Plexus Block

Keywords

Dexmedetomidine, Randomized Controlled Trial., Supraclavicular Plexus Block, bupivacaine, Palestine

Brief summary

In this study, we will assess the effect of combined Dexmedetomidine and Bupivacaine analgesia on the onset and duration of anesthesia in supraclavicular plexus block compared to Bupivacaine alone.

Detailed description

Participants who fulfill the inclusion criteria will be enrolled in this study to achieve sample size of 140 participants, 70 participants in each group. Participants were blindly randomized into two groups: group A (Bupivacaine alone) and group B (Bupivacaine with Dexmedetomidine). On the morning of the surgery day, and before performing the procedure on the targeted hand, a venous cannula 18gauze was secured on the opposite hand. Routine monitors like pulse oximetry, non-invasive blood pressure, and electrocardiogram were attached during the procedure. Study medications were prepared for each group, which is Bupivacaine (30ml) only for group A and Bupivacaine (30 ml) with Dexmedetomidine (1 mcg /kg) for group B. Then, SCPB was done under ultrasound guidance which increases the safety due to improved monitoring of anatomy and needle placement. A needle was placed within the brachial plexus sheath posterior to the subclavian artery, and the local anesthetic injected to surround the trunks and divisions of the brachial plexus at this level. Patients were evaluated for the onset of the sensory and motor block every 3 minutes after completion of injection till their onset, and, at 15, 30, 45, 60, 90, and 120 min; and then hourly (even after surgery), until they had resolved.

Interventions

DRUGDexmedetomidine

Highly selective α2-adrenergic receptor agonist. With sedative, analgesic, peri-operative sympatholytic and hemodynamic stabilizing properties.

Sponsors

Zaher Nazzal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 18-75 years. * Classified as grades 1 or 2 by the American Society of Anesthesiology Classification of .physical status. * Willing and able to sign a consent form.

Exclusion criteria

* Patients under the following conditions will be excluded: Known hypersensitivity to Bupivacaine, Dexmedetomidine, and local anesthetics. * Uncontrolled diabetes mellitus. * Peripheral neuropathy. * SevereCoagulopathy. * Infection at the site of block. * Pregnancy. * Cardiac arrhythmias. * Prescription of beta blockers. * Psychological disorders.

Design outcomes

Primary

MeasureTime frameDescription
The onset of anaesthesia in supraclavicular plexus blockup to 9 hoursSensory block assessed by pinprick test with a blunt 25-G hypodermic needle. Grade 0: sharp pin sensation felt, grade 1: analgesia, dull sensation felt, grade 2: anesthesia, no sensation felt the onset of sensory block is the interval between the end of total local anesthetic administration and sensory block grade 1
The duration of anesthesia in supraclavicular plexus blockup to 9 hoursThe motor blockade assessed using the Modified Bromage scale (MBS). Grade 0: able to raise the extended arm to 90 degrees for 2 seconds; grade 1: able to bend the elbow and move the fingers but not the extended arm; grade 2: unable to flex the elbow but able to move the fingers; grade 3: unable to move the arm, elbow, and fingers. The onset of the motor blockade is the interval from injection of the local anesthetic to motor analysis equivalent to Bromage score 2

Secondary

MeasureTime frameDescription
Intraoperative somnolence1 hourSomnolence assessed using Ramsay Sedation Scale. It grades somnolence on a scale of 1-6: 1 = anxious, agitated, restless; 2 = cooperative, oriented, tranquil; 3 = responds to commands only; 4 = brisk response to light glabellar tap or loud noise; 5 = sluggish response to light glabellar tap or loud noise; 6 = no response
Post-operative heart rateup to 6 hoursHeart rate per min is assessed postoperatively
Intraoperative heart rate1 hourHeart rate per min is assessed intraoperatively
Post-operative somnolenceup to 6 hoursSomnolence assessed using Ramsay Sedation Scale. It grades somnolence on a scale of 1-6: 1 = anxious, agitated, restless; 2 = cooperative, oriented, tranquil; 3 = responds to commands only; 4 = brisk response to light glabellar tap or loud noise; 5 = sluggish response to light glabellar tap or loud noise; 6 = no response
Number of Participants With Postoperative nausea and vomiting.up to 6 hoursVomiting assessed by mentoring the patients actively. Nausea assessed by asking the patients directly.
Post-operative blood pressureup to 6 hoursBlood pressure assessed by a non-invasive monitor
Intraoperative blood pressure as mm Hg1 hourBlood pressure assessed by a non-invasive monitor

Countries

Palestinian Territories

Contacts

Primary ContactZaher Nazzal, MD
znazzal@najah.edu(+970) 9 2345113

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026